Company profile
OpenEvidence
Artificial intelligence, Healthcare technology ยท Series D
OpenEvidence is an American artificial intelligence company that develops a medical search engine used by physicians for clinical decision support. The platform provides an AI-based tool that analyzes and organizes peer-reviewed medical literature from various clinical journals. The company's goal is to address information overload and physician shortages by providing a medical chat interface that draws answers from millions of peer-reviewed medical publications.
Stage
Series D
Total Raised
$700.0M
Founded
2022
Employees
~111
Valuation
$12.0B
HQ
Miami, Florida, United States
Funding Rounds
Recorded financings and participating investors compiled from public announcements and company disclosures.
- Jan 2026Series DThrive Capital, DST Global$250.0MRaisedJan 2026Series DThrive Capital, DST Global$250.0MRaised
- Oct 2025Series CGV, Sequoia Capital, Kleiner Perkins, Blackstone, Thrive Capital, Coatue, BOND, Craft Ventures$200.0MRaisedOct 2025Series CGV, Sequoia Capital, Kleiner Perkins, Blackstone, Thrive Capital, Coatue, BOND, Craft Ventures$200.0MRaised
- Jul 2025Series BGoogle Ventures, Kleiner Perkins, Sequoia Capital, Coatue, Conviction, Thrive$210.0MRaisedJul 2025Series BGoogle Ventures, Kleiner Perkins, Sequoia Capital, Coatue, Conviction, Thrive$210.0MRaised
Team
Team
DN
Daniel Nadler
Co-Founder & CEO
ZZ
Zachary Ziegler
Co-Founder & CTO
TZ
Travis Zack
Chief Medical Officer